FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395765000: Lanreotide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469705013 Lanreotide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489407013 Lanreotide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
60031000195113 lanreotide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
819861000172111 lanréotide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
75301000195117 Lanreotid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanreotide (substance) Is a Somatostatin analog (substance) true Inferred relationship Some
Lanreotide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hypothalamic inhibiting factor (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing lanreotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lanreotide (substance) Inferred relationship Some 1
Lanreotide 30mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide acetate 38mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide 60mg/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide 90mg/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide 120mg/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide acetate 30mg/vial injection suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide 60mg/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide 90mg/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide 120mg/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lanreotide (substance) Inferred relationship Some
Lanreotide acetate (substance) Is a False Lanreotide (substance) Inferred relationship Some
Lanreotide acetate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Lanreotide (substance) Inferred relationship Some
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lanreotide (substance) Inferred relationship Some 1
Lanreotide-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lanreotide (substance) Inferred relationship Some 1
Product containing only lanreotide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lanreotide (substance) Inferred relationship Some 1
Product containing only lanreotide in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lanreotide (substance) Inferred relationship Some 1
Product containing precisely lanreotide (as lanreotide acetate) 180 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lanreotide (substance) Inferred relationship Some 1
Lanreotide (as lanreotide acetate) 120 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lanreotide (substance) Inferred relationship Some 1
Lanreotide (as lanreotide acetate) 240 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lanreotide (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start